DE1793794A1 - Pharmazeutische zusammensetzungen - Google Patents

Pharmazeutische zusammensetzungen

Info

Publication number
DE1793794A1
DE1793794A1 DE19661793794 DE1793794A DE1793794A1 DE 1793794 A1 DE1793794 A1 DE 1793794A1 DE 19661793794 DE19661793794 DE 19661793794 DE 1793794 A DE1793794 A DE 1793794A DE 1793794 A1 DE1793794 A1 DE 1793794A1
Authority
DE
Germany
Prior art keywords
compositions according
group
denotes
steroid
unit contains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19661793794
Other languages
German (de)
English (en)
Inventor
Derek Harold Richard Barton
Robert Hesse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Institute for Medicine and Chemistry Inc
Original Assignee
Research Institute for Medicine and Chemistry Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Institute for Medicine and Chemistry Inc filed Critical Research Institute for Medicine and Chemistry Inc
Publication of DE1793794A1 publication Critical patent/DE1793794A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19661793794 1965-12-17 1966-12-17 Pharmazeutische zusammensetzungen Pending DE1793794A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51469165A 1965-12-17 1965-12-17

Publications (1)

Publication Number Publication Date
DE1793794A1 true DE1793794A1 (de) 1975-07-31

Family

ID=24048303

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19661593348 Expired DE1593348C3 (de) 1965-12-17 1966-12-17 Verfahren zur Herstellung von 19-Fluorsteroidepoxyden und 19-Fluor-11,19epoxysteroide
DE19661793794 Pending DE1793794A1 (de) 1965-12-17 1966-12-17 Pharmazeutische zusammensetzungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19661593348 Expired DE1593348C3 (de) 1965-12-17 1966-12-17 Verfahren zur Herstellung von 19-Fluorsteroidepoxyden und 19-Fluor-11,19epoxysteroide

Country Status (9)

Country Link
BE (1) BE691320A (es)
CH (1) CH587290A5 (es)
DE (2) DE1593348C3 (es)
DK (1) DK123407B (es)
FR (2) FR1511151A (es)
GB (1) GB1177648A (es)
IL (1) IL27072A (es)
NL (1) NL6617739A (es)
SE (1) SE348190B (es)

Also Published As

Publication number Publication date
GB1177648A (en) 1970-01-14
NL6617739A (es) 1967-06-19
FR6920M (es) 1969-05-05
DK123407B (da) 1972-06-19
DE1593348B2 (de) 1974-07-18
FR1511151A (fr) 1968-01-26
SE348190B (es) 1972-08-28
BE691320A (es) 1967-06-16
IL27072A (en) 1972-07-26
DE1593348A1 (de) 1970-07-30
CH587290A5 (en) 1977-04-29
DE1593348C3 (de) 1975-03-06

Similar Documents

Publication Publication Date Title
DE69118494T2 (de) Kontrazeptionsverfahren und Schema
DE69118493T2 (de) Orales Kontrazeptin mit niedrigem Östrogen-Enthalt
DE2621214C3 (de) Verwendung von Stabilisatoren in Arzneimitteln mit Fumarsäuremonoäthylester und desen Mineralsalzen
DE312867T1 (de) Gallensaeure-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die sie enthalten.
DE2447699C2 (de) Steroidhaltige topische Salbengrundlage
DE2645307C2 (es)
DE3238984C2 (es)
DE1793794A1 (de) Pharmazeutische zusammensetzungen
EP0320437A3 (de) 17-Methylen- und 17-Ethyliden-Estratriene mit östrogener Wirkung
DE1768739A1 (de) Cycloaliphatische Alkylhydroxyphenylalkanoate
STRAUSS et al. Effect of Enovid on sebum production in females: A preliminary report
WO2007096088A1 (de) Gegen unreine haut und milde formen der akne wirksame zubereitungen mit einem gehalt an hydroxymatairesinol als wirksames prinzip
DE2434849A1 (de) Herzstaerkende dosierungseinheit mit einer ein praeparat enthaltenden kapsel
DE223671T1 (de) Arzneimittel mit synergistischer entzuendungshemmender wirkung auf der basis eines corticosteroiden und eines beta-agonisten.
DE1617871A1 (de) Verfahren zur Herstellung einer stabilen waesserigen Loesung
DE975623C (de) Wirkstoffe, z. B. Desinfektionsmittel, und hoehermolekulare Fettalkohole sowie Fettalkoholsulfate enthaltende fluessige Mund- und Zahnpflegemittel
DE2539824A1 (de) Pharmazeutische zubereitung
US2381830A (en) Medicinal preparation
DE1909276A1 (de) Transparente fluessige kosmetische Zubereitungen
DE3240044A1 (de) Verwendung von 17(alpha)-acyloxy-6-methylpregna-4,6-dien-3,20-dionen zur bekaempfung von brustkrebs
DE1667931C (de) Arzneimittel gegen Koronarinsuffizienz
DE2325809A1 (de) Hautmittel
DE2008621A1 (de) Schwangerschaftsverhütende Mittel
DE2059338A1 (de) Arzneimittel auf der Basis von Cyproteron und dessen Estern sowie Methode zur Behandlung der Pubertas praecox
DE1617818B2 (de) Oral verabreichbare oder injizierbare antikonzeptionsmittel